CLL: Treatment and Management Strategies for Best Outcomes - Episode 6
Josie Montegaard, MSN, AGPCNP-BC, offers expert perspectives on treatment considerations in CLL, focusing on BTK inhibitors and venetoclax-based therapy.
Related Content:
Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation
Sasanlimab-BCG Combo May Delay Recurrence in Bladder Cancer
Personalized Vaccine Elicits Responses in Patients With Kidney Cancer
The Invisibility of Blood Cancers to Others